. . . . . . . . . . . . . "p(HGNC:IFNB1) -> p(HGNC:CTLA4)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Moreover, IFN-beta therapy increases expression of the CTLA4 molecule, which induces a counterregulatory Th2 response." . . "Selventa" . . . . "2014-07-03T14:30:14.684+02:00"^^ . . .